They are funded through until at least mid next year by which time they will have results of three phase 2 trials. The most important milestone this year is the interim data release for SNT 5505 in myelofibrosis - and a presentation at ASH in December. Spec buy and hold until then in my opinion.
- Forums
- ASX - By Stock
- Ann: Phase 2 Trial Reaches 50% Recruitment
They are funded through until at least mid next year by which...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.8¢ |
Change
-0.002(5.00%) |
Mkt cap ! $45.37M |
Open | High | Low | Value | Volume |
4.1¢ | 4.1¢ | 3.5¢ | $92.49K | 2.439M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15261 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 33701 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15261 | 0.038 |
1 | 25000 | 0.037 |
1 | 113863 | 0.035 |
2 | 425000 | 0.033 |
4 | 670000 | 0.031 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 33701 | 1 |
0.040 | 539251 | 4 |
0.041 | 141890 | 1 |
0.045 | 45224 | 1 |
0.047 | 88965 | 2 |
Last trade - 15.44pm 19/07/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |